TITLE: Safety, Tolerability and
Immunogenicity of GS-4774, an HBV-specific Therapeutic Vaccine, in Healthy Volunteers
AUTHORS (FIRST NAME, LAST NAME): Anuj Gaggar1, Claire Coeshott2, Mani Subramanian1, John G. McHutchison1, David Apelian2
Institutional Author(s):
INSTITUTIONS (ALL): 1. Gilead Sciences, Foster City CA, CA, United States.
2. Globeimmune, Louisville, CO, United States.